Open AccessTh17 Cells: Can Epigenetic Manipulation and Artificial T cell Receptors Make Th17 cells Efficient Immunotherapeutic Anti-Tumor Effector T Cells?
Author(s) -
Michael P. Alexander
Publication year - 2016
Publication title -
moj immunology
Language(s) - English
Resource type - Journals
ISSN - 2373-4442
DOI - 10.15406/moji.2016.04.00119
Subject(s) - immunopharmacology , effector , tumor immunology , receptor , microbiology and biotechnology , epigenetics , biology , immunotherapy , immunology , immune system , biochemistry , gene